Patanjali unit asked to stop production of Bpgrit, Madhugrit and 3 other medicines

Published On 2022-11-12 12:09 GMT   |   Update On 2022-11-12 12:10 GMT
Advertisement

Dehradun, Uttarakhand Ayurveda, and Unani Licensing Authority has asked Divya Pharmacy to stop the production of five medicines and produce their revised formulation sheets for approval. Divya Pharmacy manufactures Yoga guru Ramdev's Patanjali products.

According to the notice issued on Wednesday, Bpgrit, Madhugrit, Thyrogrit, Lipidom tablets, and Eyegrit Gold tablets are being promoted as medicines for blood pressure, diabetes, goitre, glaucoma, and high cholesterol.
For more details, check out the link given below:
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News